OUR 1-2-3 TRANSDERMAL FEASIBILITY PROGRAM
Have a clinical stage asset? A commercially approved product? At Corium Innovations, we’re ready to tailor a rapid, smart-priced feasibility program to test the technical viability of producing a multi-day delivery transdermal system for your drug.
As the market leader in advanced transdermal drug delivery and polymer science, we’ll use our expertise in both formulation and process to produce working prototypes based on our flexible Corplex® 7-day technology.
We’ll subject them to skin-flux models to predict overall drug absorption and drug uptake duration. Plus, perform abbreviated physical and chemical testing on the prototypes. And summarize the findings in a concise development report—including our professional recommendations. All in just 60 days.
Here’s how it works:
Stage 1 PAPER SCREENING
- Assess key drug properties
- Determine partner/patient clinical demand
- Model potential for skin irritation
- Score quantitative likelihood of formulation success
Completion time: 1-2 weeks
Stage 2 SOLUBILITY STUDY
- Determine drug solubility in multiple GRAS excipients and process aids
- Determine gross compatibility of multiple adhesive mixes
- Map prototype formulation from combined results
Completion time: 2-3 weeks
Stage 3 SKIN FLUX TESTING
- Produce 3-5 patch prototypes
- Run skin flux testing (N=3) on all test patch systems
- Perform physical + chemical testing of the systems
- Issue report of generated data and recommendations
Completion time: 3-4 weeks
For more information
contact: Dwayne Sharpe
Director of business development
Corium
INNOVATIONS
at a glance
-
Founded in 1999
Transdermal/oral thin film experts
-
FDA/DEA
registered facilities
-
Rx and OTC
manufacturing